A Plus Biotechnology Co., Ltd. (TPE:6918)
Taiwan · Delayed Price · Currency is TWD 73.00
-1.10 (-1.48%)
Oct 30, 2026, 1:23 PM CST
A Plus Biotechnology Financials Overview
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 887.93 | 835.89 | 769.59 | 675.05 | 615.48 | 541.85 |
Revenue Growth | 8.94% | 8.62% | 14.01% | 9.68% | 13.59% | 7.66% |
Gross Profit Gross Profit Growth | 592.91 | 573.46 | 534.78 | 460.67 | 371.53 | 346.39 |
Operating Income Operating Income Growth | 213.27 | 208.76 | 182.46 | 167.54 | 66.98 | 46.74 |
Net Income Net Income Growth | 185.79 | 169.38 | 151.06 | -11.31 | 45.7 | 32.94 |
Earnings Per Share EPS Growth | 5.40 | 5.15 | 4.97 | -0.37 | 1.50 | 1.14 |
EPS Growth | 0.51% | 3.62% | - | - | 31.57% | -9.44% |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Taiwan Taiwan Growth | 771.11 | 727.17 | 668.5 | 595.9 | 570.89 |
China China Growth | 197.22 | 175.3 | 161.55 | 151.52 | 159.09 |
Adjustment and Write-Off Adjustment and Write-Off Growth | -80.39 | -66.58 | -60.45 | -72.38 | -114.5 |
Total Total Growth | 887.93 | 835.89 | 769.59 | 675.05 | 615.48 |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 480.56 | 608.35 | 390.97 | 319.07 | 237.69 | 305.09 |
Total Debt Total Debt Growth | 168.55 | 96.1 | 106.81 | 113.03 | 138.9 | 212.24 |
Net Cash (Debt) Net Cash Growth | 312.01 | 512.26 | 284.16 | 206.03 | 98.79 | 92.85 |
Net Cash Growth | -44.73% | 80.27% | 37.92% | 108.55% | 6.40% | -62.95% |
Net Cash Per Share Net Cash Per Share Growth | 9.06 | 15.57 | 9.36 | 6.81 | 3.23 | 3.22 |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 169.55 | 158.91 | 160.96 | 159.1 | 60.64 | 52.95 |
Capital Expenditures CapEx Growth | -136.39 | -14.12 | -8.87 | -9.38 | -35.12 | -221.5 |
Free Cash Flow Free Cash Flow Growth | 33.15 | 144.79 | 152.09 | 149.72 | 25.52 | -168.55 |
Free Cash Flow Growth | -79.90% | -4.80% | 1.58% | 486.62% | - | - |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 66.77% | 68.60% | 69.49% | 68.24% | 60.37% | 63.93% |
Operating Margin | 24.02% | 24.98% | 23.71% | 24.82% | 10.88% | 8.63% |
Pretax Margin | 26.42% | 25.86% | 24.37% | 0.45% | 11.07% | 8.50% |
Profit Margin | 20.92% | 20.26% | 19.63% | -1.68% | 7.43% | 6.08% |
FCF Margin | 3.73% | 17.32% | 19.76% | 22.18% | 4.15% | -31.11% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 5.000 | 5.000 | 4.000 | 2.700 | 0.700 | 0.500 |
Dividend Per Share Growth | 25.00% | 25.00% | 48.15% | 285.71% | 40.00% | 0% |
Dividend Yield | 6.85% | 5.70% | 4.99% | 5.96% | - | - |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 13.52 | 17.45 | 16.18 | - | - | - |
P/FCF Ratio | 75.02 | 20.41 | 16.07 | 9.13 | - | - |
PS Ratio | 2.80 | 3.54 | 3.18 | 2.03 | - | - |